EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of key lncRNAs associated with oxaliplatin resistance in colorectal cancer cells and isolated exosomes: From In-Silico prediction to In-Vitro validation

Roxana Sahebnasagh iD, Hoda Deli iD, Amir Shadboorestan, Zeynab Vakili-Ghartavol, Najmeh Salehi iD, Tahereh Komeili-Movahhed, Zahra Azizi, Mohammad Hossein Ghahremani iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0311680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Roxana Sahebnasagh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Exosomes, Colorectal Neoplasms, Oxaliplatin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the critical challenges in managing colorectal cancer (CRC) is the development of oxaliplatin (OXP) resistance. Long non-coding RNAs (lncRNAs) have a crucial role in CRC progression and chemotherapy resistance, with exosomal lncRNAs emerging as potential biomarkers. This study aimed to predict key lncRNAs involved in OXP-resistance using in-silico methods and validate them using RT-qPCR methods in CRC cells and their isolated exosomes. Two public datasets, GSE42387 and GSE119481, were downloaded from the GEO database to identify differentially expressed genes (DEGs) and miRNAs (DEmiRNAs) associated with OXP-resistance in the HCT116 cell line. The analysis of GSE42387 revealed 210 DEGs, and GSE119481 identified 73 DEmiRNAs. A protein-protein interaction (PPI) network analysis of the DEGs identified 133 interconnected genes, from which the top ten genes with the highest degree scores were selected. By intersecting predicted miRNAs targeting these genes with the DEmiRNAs, 38 common miRNAs were found. Subsequently, 224 lncRNAs targeting these common miRNAs were predicted. LncRNA-miRNA-mRNA network were constructed and the top five lncRNAs with the highest degree scores were identified. Analysis using the Kaplan-Meier plotter database revealed that the key lncRNAs NEAT1 , OIP5-AS1 , and MALAT1 are significantly associated with the overall survival of CRC patients. To validate these lncRNAs, OXP-resistant HCT116 sub-cell line (HCT116/OXR) was developed by exposing parental HCT116 cells to gradually increasing concentrations of OXP. Exosomes derived from both HCT116 and HCT116/OXR cells were isolated and characterized utilizing dynamic light scattering (DLS), transmission electron microscopy (TEM), and Western blotting. RT-qPCR confirmed elevated levels of NEAT1 , OIP5-AS1 , and MALAT1 in HCT116/OXR cells and their exosomes compared to parental HCT116 cells and their exosomes. This study concludes that NEAT1 , OIP5-AS1 , and MALAT1 are associated with the OXP-resistance in CRC. The high levels of these lncRNAs in exosomes of resistant cells suggest their involvement in intercellular communication and resistance propagation. This positioning makes them promising biomarkers for OXP-resistance in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingExosomesColorectal NeoplasmsOxaliplatinDrug Resistance, NeoplasmMicroRNAsHumansHCT116 CellsGene Expression Regulation, NeoplasticComputer SimulationGene Regulatory NetworksProtein Interaction MapsAntineoplastic Agents

Substanzen

RNA, Long NoncodingOxaliplatinMicroRNAsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Toxicology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • School of Biology, College of Science, University of Tehran, Tehran, Iran.
  • Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.
  • Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Roxana Sahebnasagh, Hoda Deli, Najmeh Salehi, Mohammad Hossein Ghahremani

Förderung

  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Sahebnasagh, R., Deli, H., Shadboorestan, A., Vakili-Ghartavol, Z., Salehi, N., Komeili-Movahhed, T., Azizi, Z., & Ghahremani, M. H. (2024). Identification of key lncRNAs associated with oxaliplatin resistance in colorectal cancer cells and isolated exosomes: From In-Silico prediction to In-Vitro validation. PLOS ONE. https://doi.org/10.1371/journal.pone.0311680

Vancouver

Sahebnasagh R, Deli H, Shadboorestan A, Vakili-Ghartavol Z, Salehi N, Komeili-Movahhed T, et al. Identification of key lncRNAs associated with oxaliplatin resistance in colorectal cancer cells and isolated exosomes: From In-Silico prediction to In-Vitro validation. PLOS ONE. 2024. doi:10.1371/journal.pone.0311680

BibTeX
@article{Sahebnasagh2024,
  author = {Sahebnasagh, Roxana and Deli, Hoda and Shadboorestan, Amir and Vakili-Ghartavol, Zeynab and Salehi, Najmeh and Komeili-Movahhed, Tahereh and Azizi, Zahra and Ghahremani, Mohammad Hossein},
  title = {Identification of key lncRNAs associated with oxaliplatin resistance in colorectal cancer cells and isolated exosomes: From In-Silico prediction to In-Vitro validation},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0311680}
}
Kostenlos starten →